高锶矿泉水研究简报_第1页
高锶矿泉水研究简报_第2页
高锶矿泉水研究简报_第3页
高锶矿泉水研究简报_第4页
高锶矿泉水研究简报_第5页
已阅读5页,还剩16页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

泸云矿水限司研简一长江雪岭锶矿泉水对养人肝细胞增及功能的影目胞LO2增殖和方:LO2MTT法检测其增殖活力,并测定培养上清液中AST、ALT的代于96孔板每孔的细胞×10

/ml、4mg/L、6mg/L含含锶的2mg/L、4mg/L组、6mg/L组和8mg/L组2天、天和用MTT并在第4天取培定AST及结:胞3天后2mg/L4mg/L6mg/L8mg/L组肝细接种5天与空白组相

中4mg/L和6mg/L组种7天后6mg/L差异中AST及ALT异具、2mg/L及6mg/L组AST及ALT酶2mg/L与空白组比较对照、、6mg/L组培养差异具显著性中6mg/L组总胆红在一定浓锶矿低ASTALT酶年10月18日/p>

泸云矿水限司研简二长江雪岭锶矿泉水对Wistar大鼠Ⅰ型糖尿的影响可现代科学已证实糖尿病与人(strontium,Sr)39微克,成年人锶2锶与疾病高锶wistar大鼠I型≥目:对I型糖尿病大鼠的血糖方:克,雄雌各半,一次性(STZ)60复制I型糖尿病模型3天

达(DM鼠DM鼠随机Sr2mg/L(组)、Sr4mg/L(B组)组Sr6mg/L长C长组DM组(N=32)DM组分别于第12个月、第34个月随机处死游离结:(GLu血乳酸(LD第1、2、3、4,、、C、D与DM组(P>0.05白GHb)1月,B、组糖化血红蛋白较DM(2、、4月,A、、C、D组(NEFA1、月,、、C、D组均较组明显(3、月,D组较(1月组均较DM组明显P<0.05D(P<0.012月,DM组明显(3、月A、、、与DM

醇1月,、、、与DM第2,组DM34A组DM组比较结:在型糖油对型糖I病年10月18/p>

泸云矿水限司研简三不同浓度长江雪岭高矿泉水对HK-2细胞增殖及的影响背目前定范围内高浓度的锶对人体健康是目:HK-2人其方代于96孔板为5×104/ml8h含锶矿泉水、6mg/L含的DMEM培养2mg组组、37℃、296h和育4h,出现溶解液100ul,置于长570nm处读取OD.根据吸光值并65×4/ml24h

8个复孔。-20融次,刮刀收集测ATP酶活性。果:和6mg/L浓度的含细胞的增(p<0.05浓力P<0.05)。4mg/L6mg/L能年10月18日/p>

泸云矿水限司研简四长江雪岭锶矿泉水对尿酸血症(痛风)大鼠的影响strontium,,成年目方:年Wistar大鼠200只200206克克体第0第20显示随后+

为的+饮水、高尿酸血症模型组

单独饮水组别嘌呤醇+饮水组

自来水组4mg/L锶矿泉水组6mg/L锶矿泉水组8mg/L锶矿泉水组别嘌呤醇治疗自来水组别嘌呤醇治疗+锶矿泉水组别嘌呤醇治疗+锶矿泉水组别嘌呤醇治疗+锶矿泉水组醇100mg/kg灌喂组第1246周8取8血肌处死结:1P<0.05+各高锶矿泉水组与别嘌呤治疗+(P(P>0.052疗+各高疗尿(P>0.05嘌呤治+疗+P<0.05

疗后疗后周别疗疗4mg/L锶P疗第周。江雪含为的高测病理生理学教研室年10月16日/p>

TheBrief1TheEffectofChangJiangMountainsHighConcentrationMineralOnLiverLO2Proliferationand:TotheofdifferentonhepatocytesproliferationandPreparedculturemediumswaterscontainingandcellstheCellproliferationwasanalyzedbyMTTassay;ASTandALTactivitycontentoftotalbytestkitTheproliferationofCellshowedsignificantdifferences3ineachgroup.thetheofwater,2mg/Land4mg/LgroupcanenhanceproliferationofLO2cellsignificantly,comparedthe,proliferationof6mg/Lgroupnodifference,andlag;Atdaysthetheandeachofthedifferentofstrontium-containingstimulatethecellproliferation,4mg/L6mg/Lcomparedaredifference.At7daysinadditionthethegroupsshowncertaindegreeofinhibition,proliferationof4mg/Land6mg/Lstillbettergroups,but8mg/Lgroupshowed

inhibition.ComparedwiththetheASTandALTactivityofcontrolgroupandwerelower,butthenon-significantbetweenthecontrol2mg/L,4mg/L6mg/LASTandALTactivity8mg/Lwasgroups.totalcontentof2mg/Lhigherthantheothergroupssignificantly;theblankthecontrol4mg/L6mg/Lgroupand8mg/Lgrouptotalwere6mg/Lminimum.Inarangeofconcentration,enhanceculturedcell(LO2)proliferation;canandALTactivityreduceandenhancetheofstrontium;humancellproliferation;ALT;AST;totalbilirubin.ofLuZhoumedical18.Oct.2011

TheBrief2oftheChangJiangSnowyMineralWaterwithConcentrationonTypeIModelsoftraceandtheofbodythefieldsinternationalscientificSomearerelatedtoandconditionofglucoseintheconfirmed,thelackofbodyessentialtracesuchchromium,selenium.that,belongsthemetal,andisalsoakindoftraceelementhumanbody.contentofSr39ug/Lintheblood,andThereislittlestudyabouttheofSrandlittlereportabouttheEffectoftheonstudywastodiscusstheofChangMountainsWaterHighConcentration(cantheevidencetherelationshipSrandTotheofChangMountainsdifferentofoncontentbloodglucose,bloodlactictriglycerides,fattyinI’220~250g,halfmalehalf

theexperiment.injectionofStreptozotocin(STZ)60mg/kgwasdayslater,thefastingglucosethediabetes(DMThenDMrandomlydividedA,ratsdrinkingChangMountainsWaterConcentrationSr2mg/LratsdrinkingChangMoutains4mg/L;groupC,drinkingSnowyMoutanisnaturalSr6mg/L;groupD,ratsdrinkingChangMoutainsnaturalmineral8mg/LDMratsdringkingwater,ratsineachgroup(N=32).ineachgroupaftermonth,thesecondthethirdmonths,andfourthmonthwererandomlyandbloodcollected.Thenthebloodofbloodglycosylatedtriglycerides,fattyinsulin.Therenodifferencethecontentofbloodglocoseacid(LD),insulinbetweenA,B,andDMatend1,2,mo.(>(GHb):Attheof1theofglycatedhemoglo-bingroupDMgroup(PAtthe3,mo,theredifferenceA,C,groupandDMFreefattyacid:Attheend1,2ofNEFAinA,B,wereobviouslythanDMgroup(<Attheendof3mo,theofNEFAinthanDM(<0.05).Triglycerides(TG):Atendof1mo,ofTGinwereobviouslydecreasedcomparedtoDM(PespeciallyingroupD(<Attheendofmo,theof

inthanDMgroup<Attheend3,4therenobetweenA,C,andDM(TC):Atendof1theresignificantbetweenA,B,C,DandDMAtcontentofTCinthanDM(P<0.05);Attheof3andmo,therewasnobetweenB,C,andDMMountainsHighConcentrationansignificantreducingblood-lipoidsIdiabetestheearlystage,obviouslyofnon-esterifiedfattyMountainsHighConcentrationnoofreducingglycatedImellitusMountainsConcentrationnotheofIofPathophysiologymedicalcollege18.Oct.2011

TheBrief3TheEffectofChangJiangMountainsMineralWaterConcentrationonHK-2CellsProliferationandtheActivityofATPEnzymeBackground:Alevelstrontiumtheofhumanbeing,however,notreporteffectstrontiumtheeffectofwaterscontainingdifferentstrontiumcellproliferationandATPenzymeactivity.Preparedthemediumswaterscontainingdifferentculturedcellsthem.CellproliferationbyMTTassay,ATPactivitywasbyATPHK-2cellioncycleprolongedbythestrontiumwaters4mg/Landsixmg/LSrsignificantly,theprosperousproliferationbemorelongerthanblanket<0.05);Strontiumwater2-8mg/LSrcanenhancecellsATPenzymeactivity(p0.05).mineralwater4mg/LSrgood

ofLuZhoumedical18.Oct.2011

TheBriefReport4TheEffectsofChangjiangSnowyMountainsStrontiumhyperuricemiaHyperuricemiaisadiseasehazardstohealthseriously.showntraceelementsrelateddiseases,asdiabetes.(Sr)akindessentialbody.Normalcontent39ug/Linblood.AneedsmgSreveryonrelationshipSrandisalittle,theConcentrationonhyperuricemianotresearchratstohyperuricemiaordertostudytheofChangjiangMountainsStrontiumohyperuricemia(gout).Itwillexperimentalto(gout).TotheofMountainsConcentrationStrontiumonhyperuricemia(gout)throughbloodnitrogenuricacid.Methods:adult±wererandomly

intohyperuricemiagroup.Thehyperuricemiagroupgivenmixturewithyeastaof6g/100gbodydays.groupwerefedratequivalently.Inthe10and20bloodinweretoacidlevel.20daysuricofmixedfedwerehigherthanthatintheitshowedhyperuricemiamodelweresuccessfully.Thenratsinhyperuricemiagrouprandomlydividedintodrinkinggroupand+groupincludedstrontiumquantitymg/L,mg/L,groupandtapAstableinallopurinol+drinkinggroupwerefed100mg/kgbodyweight.Allfednormalfodder.ratswerethe2weeks,weeks.SerumureanitrogenbloodandxanthineoxidasewereandwereassessedbyTable:groupwererandomlyintogroup

tapwatergroupDrinking4mg/LSrmineralgroupwatergroup6mg/LSrmineralgroup8mg/LSrmineralgroupAllopurinolallopurinolgroup

drinkingwatergroup

SrmineralgroupSrmineralgroupSrmineralgroup(1)1uricofdrinkingmineralStrontiumgroupswere<0.05)thantapuricofallopurinol+drinkingConcentration(p<allopurinol+drinkingtapcreatinine,andnitrogeneachno(2)2treatment,drinkingwaterno(P>0.05);uricacidofallopurinol+drinkinggroups

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论